Copyright
©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Oct 21, 2011; 17(39): 4434-4439
Published online Oct 21, 2011. doi: 10.3748/wjg.v17.i39.4434
Published online Oct 21, 2011. doi: 10.3748/wjg.v17.i39.4434
Control (n = 18) | Obese (n = 16) | Octreotide treated (n = 15) | |
Body weight (g) | 378.54. ± 111.75 | 605.61 ± 141.00b | 508.27 ± 94.39bc |
Lee’s index | 318.73 ± 20.10 | 337.61 ± 10.82b | 334.67 ± 16.56a |
Glucose (mmol/L) | 7.33 ± 0.70 | 8.60 ± 1.38b | 7.58 ± 1.51c |
Sucrase activity (U/mg protein) | 53.84 ± 17.98 | 48.90 ± 13.95 | 35.85 ± 21.31 |
Maltase activity(U/mg protein) | 50.43 ± 30.49 | 156.01 ± 58.81b | 112.85 ± 51.86a |
Mucosa GLUT2 (IOD) | 170546.5 ± 50646.14 | 390744.2 ± 62469.21b | 269975.2 ± 53730.94bd |
Apical GLUT2 (IOD) | 354.98 ± 57.19 | 26740.18 ± 3809.60b | 3758.06 ± 364.51ad |
GLUT2 mRNA (IOD) | 0.07 ± 0.02 | 0.26 ± 0.11b | 0.08 ± 0.02bd |
Western-blotting (IOD) | 1.27 ± 0.38 | 2.08 ± 0.59b | 1.31 ± 0.29d |
- Citation: Wei N, Liu R, Ou Y, Li X, Qiang O, Guo W, Tang CW. Effects of octreotide on glucose transporter type 2 expression in obese rat small intestine. World J Gastroenterol 2011; 17(39): 4434-4439
- URL: https://www.wjgnet.com/1007-9327/full/v17/i39/4434.htm
- DOI: https://dx.doi.org/10.3748/wjg.v17.i39.4434